ISHIBASHI Hiromi | Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC) : The HLA-DRB1 polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis : A prospective, multicenter study
Risk Factors and Prediction of Long-term Outcome in Primary Biliary Cirrhosis
Human intrahepatic biliary epithelial cell as possible modulator of hepatic regeneration : Potential role of biliary epithelial cell for hepatic remodeling in vivo
Increasing hepatitis C virus-associated hepatocellular carcinoma mortality and aging : Long term trends in Japan
Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis
2-1). Antigen Peptide Analog : Induction of T cell Anergy in Primary Biliary Cirrhosis
Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices
Efficacy of early retreatment with interferon β for relapse in patients with genotype Ib chronic hepatitis C
Pilot study of prolonged interferon-α retreatment in chronic hepatitis C patients with genotype 1b
Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory
Hen and egg, you mitochondria! PBC revisits mitochondria again
Interobserver variation in assessing small bile duct lesions in PBC, CVH, and AIH

もっと見る

スポンサーリンク